INSIGHTS ON DRUG DISCOVERY

• Improving Bioprocessing Outcomes With The CHOZN® Elite Host Cell Line

  Accelerate cell line development with a host engineered for high expression, streamlined clone selection, flexible gene integration, and scalable industrial performance.

• Discovery, Characterization Of Epitope-Diverse MMR Protein Antibodies

  Learn how these high-affinity, epitope-diverse mAbs provide a powerful toolkit to dissect the role of DNA mismatch repair (MMR) proteins in HD.

• Mammalian Expression

  See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. 

• Balancing Timelines In Outsourced R&D With GXP Compliance

  Outsourced R&D balances speed and quality by integrating strong governance, clear planning, and GXP compliance, enabling efficient execution while reducing risk, rework, and development delays.

• Integrated Drug Discovery: Hit To PCC In 16 Months

  5/8/2026

  Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.

• ADC Development Grows More Complex — SPR Insights Bring Clarity

  4/14/2026

  Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

• Mammalian Cell Line Development

  3/26/2026

  Explores how modern cell line engineering boosts speed, stability, and scalability across biologics, with practical insights to cut risk and improve readiness for downstream development.

• WuXia293Stable: Express What CHO Can't

  3/26/2026

  Discover a modern 293‑based expression system built for higher purity, controlled glycosylation, and improved activity, offering a new option for teams developing complex or next‑generation biologics.

• What Matters More In DNA-Encoded Libraries?

  3/16/2026

  DELs can screen billions of compounds, but library quality determines meaningful results. See how thoughtful design shapes early decisions that influence which drug candidates move forward.